ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

May 25, 1979

Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction

July 8, 1988

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

Fruits, Vegetables Protective Against Cancer, IARC Says

May 30, 2003

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

ASCO Awards Contract For D.C. Office

January 5, 1990